A case of acute myeloblastic leukemia with a novel variant of t(8;21)(q22;q22)

International Journal of Hematology

Volumn 87, Issue 1, 2008, Pages 78-82

  Kawakami, Keiki ^a   Nishii, Kazuhiro ^b   Hyou, Ryuu ^b   Watanabe, Yasuyuki ^a   Nakao, Makoto ^a   Mitani, Hidetsugu ^a   Murata, Tetsuya ^a   Monma, Fumihiko ^b   Yamamori, Shunji ^c   Hosokai, Noboru ^c   Miura, Ikuo ^d  

^a SUZUKA GENERAL HOSPITAL   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c LSI MEDIENCE CORPORATION   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myeloblastic leukemia; Masked type translocation; T (8; 21)(q22; q22)

Indexed keywords

CD19 ANTIBODY; CD56 ANTIGEN; CYTARABINE; FLUDARABINE; IDARUBICIN; MITOXANTRONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR; TRANSCRIPTION FACTOR RUNX1;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ANAMNESIS; ARTICLE; AUTOPSY; CASE REPORT; CHROMOSOME 21; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME Q BAND; CLINICAL FEATURE; CYTOCHEMISTRY; DISEASE CLASSIFICATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KARYOTYPE; LABORATORY TEST; MALE; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ADULT; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 9; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; HEMATOPOIESIS, EXTRAMEDULLARY; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 41849120463     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-007-0010-2     Document Type: Article

References (18)

1. Rowly JD. Recurring chromosomal abnormalities in leukemia and lymphoma. Semin Hematol. 1997;27:122-36.
2. Miyoshi H, Kozu T, Shimizu K, et al. The t(8;21) tranlocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 1993;12:2715-21.
3. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:620-5.
4. TrujilloJM, Cork A, Aheam MJ, et al. Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia. Blood. 1979;53:695-706.
5. Bloomfield CD, Lawrence D, Byrd JC, et al. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res. 1998;58:4173-9.
6. Rege K, Swanbury GJ, Arta AA, et al. Disease features in acute myeloid leukemia with t(8;21)(q22;q22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival. Leuk Lymphoma. 2000;40:67-77.
7. Xue Y, Nju C, Chen S, et al. Two cases of AML(M2) with a t(8;21)(q22;q13): a new cytogenetic variant. Cancer Genet Cytogenet. 2000;118:154-8.
8. Viera L, Oliveira V, Ambrosio AP, et al. Translocation (8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia(M2): a four-way variant of t(8;21). Cancer Genet Cytogenet. 2001;128:104-7.
9. Gallego M, Carroll AJ, Gad GS, et al. Variant t(8;21) rearrangements in acute myeloblastic leukemia of childhood. Cancer Genet Cytogenet. 1994;75:139-44.
10. Osumi K, Fukui T, Kiyoi H, et al. Rapid screening of leukemia fusion transcripts in acute leukemia by real-time PCR. Leuk Lymphoma. 2002;43:2291-9.
11. Speicher MR, Ballard SG, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet. 1996;12:368-75.
12. Monma F, Nishii K, Yamamori S, et al. Fluorescent in situ hybridization analysis of Philadelphia chromosome-negative chronic myeloid leukemia with the bcr/abl fusion gene. Int J Hematol. 2004;80:155-8.
13. Foster R, Griffith R, Ferrao P, Ashman L. Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tryrosine kinase. J Mol Graph Model. 2004;23:139-52.
14. Kita K, Nakase K, Miwa H, et al. Phenotypical characteristics of acute myeloid leukemia associated with the t(8;21)(q22;q22) chromosomal abnormalitiy: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood. 1992;80:470-7.
15. Baer MR, Stewart CC, Lawrence D, et al. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). Blood. 1997;90:1643-8.
16. Nishi K, Usui E, Katayama N, et al. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML. Leukemia. 2003;17:731-7.
17. Miyamoto T, Weissman IL, Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA. 2000;97:7521-6.
18. Cairoli R, Beghini A, Grillo G, et al. Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood. 2006;107:3463-8.